Literature DB >> 34109315

Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? PRO.

Vimal K Derebail1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34109315      PMCID： PMC8186477          DOI： 10.34067/kid.0006762020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  16 in total

1.  Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies.

Authors:  C D Pusey; A J Rees; D J Evans; D K Peters; C M Lockwood
Journal:  Kidney Int       Date:  1991-10       Impact factor: 10.612

Review 2.  Role of therapeutic plasmapheresis in ANCA-associated vasculitis.

Authors:  Giles Walters
Journal:  Pediatr Nephrol       Date:  2015-05-19       Impact factor: 3.714

3.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.

Authors:  Anand Padmanabhan; Laura Connelly-Smith; Nicole Aqui; Rasheed A Balogun; Reinhard Klingel; Erin Meyer; Huy P Pham; Jennifer Schneiderman; Volker Witt; Yanyun Wu; Nicole D Zantek; Nancy M Dunbar; Guest Editor Joseph Schwartz
Journal:  J Clin Apher       Date:  2019-06       Impact factor: 2.821

4.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. Reply.

Authors:  Michael Walsh; Peter A Merkel; David R W Jayne
Journal:  N Engl J Med       Date:  2020-05-28       Impact factor: 91.245

5.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

Review 6.  Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

Authors:  Philip J Klemmer; W Chalermskulrat; Michael S Reif; Susan L Hogan; David C Henke; Ronald J Falk
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

7.  Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear.

Authors:  Michael Walsh; Alina Casian; Oliver Flossmann; Kerstin Westman; Peter Höglund; Charles Pusey; David R W Jayne
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

8.  Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.

Authors:  Taewoo Lee; Adil Gasim; Vimal K Derebail; Yunro Chung; JulieAnne G McGregor; Sophia Lionaki; Caroline J Poulton; Susan L Hogan; J Charles Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

9.  Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database.

Authors:  Eishi Uechi; Masato Okada; Kiyohide Fushimi
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

Review 10.  Anti-Glomerular Basement Membrane Disease.

Authors:  Stephen P McAdoo; Charles D Pusey
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-17       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.